Skip to main content
Top

Advances in Therapy

Issue 6/2023

Content (20 Articles)

Open Access Insomnia Summary of Research

Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)

Stacie Hudgens, Andrea Phillips-Beyer, Louise Newton, Dalma Seboek Kinter, Heike Benes

Open Access Bronchial Asthma Review

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma

John Haughney, Tonya Winders, Steve Holmes, Pascal Chanez, Andrew Menzies-Gow, Janwillem Kocks, Adel H. Mansur, Christopher McPherson, Giorgio Walter Canonica

Open Access Acute Coronary Syndrome Review

Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials

Patrick Savage, Brian Cox, Michael Shahmohammadi, Johnathan Foster, Ian Menown

Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review

Amber N. Edinoff, Natalie W. Wu, Katelyn Parker, Edwin Dudossat, Lauren Linquest, Chelsi J. Flanagan, Anam Dharani, Hirni Patel, Olga Willett, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye

Open Access Statins Original Research

Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain

Juan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, Miriam Fernández, Sandra Merino-Montero, Alberto Zamora

Open Access Expert Opinion Original Research

The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial

Bartholomeus J. A. Willigers, Mario Ouwens, Andrew Briggs, Hiddo J. L. Heerspink, Carol Pollock, Roberto Pecoits-Filho, Navdeep Tangri, Csaba P. Kovesdy, David C. Wheeler, Juan Jose Garcia Sanchez

Open Access Paroxysmal Nocturnal Hemoglobinuria Original Research

Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations

Imre Bodó, Ismail Amine, Ana Boban, Horia Bumbea, Alexander Kulagin, Elena Lukina, Agnieszka Piekarska, Irena Preloznik Zupan, Juraj Sokol, Jerzy Windyga, Jaroslav Cermak

Open Access Colectomy Original Research

Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USA

Thomas Lodise, Amy Guo, Min Yang, Erin E. Cook, Wei Song, Danni Yang, Qingyuan Wang, Angela Zhao, Markian Bochan

Open Access Antibiotic Original Research

Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US

Thomas Lodise, Amy Guo, Min Yang, Erin E. Cook, Wei Song, Danni Yang, Qingyuan Wang, Angela Zhao, Markian Bochan

Open Access Melanoma Original Research

Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection

Cesar Lopez-Vinueza, Juan Urrego-Reyes, Fredy R. S. Gutierrez, Victoria Wurcel, Shujing Zhang, Shan Jiang, Ruixuan Jiang, Angela Zambrano Harvey, Praveen Dhankhar, Baanie Sawhney, Gargi Baluni, Shrishti Jain, Debosmita Bhadra

Open Access Chronic Kidney Disease Original Research

Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study

Navdeep Tangri, Emily J. Peach, Stefan Franzén, Salvatore Barone, Pamela R. Kushner

Open Access Chronic Kidney Disease Original Research

Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study

Abiy Agiro, Amin AN, Erin E. Cook, Fan Mu, Jingyi Chen, Pooja Desai, Yemmie Oluwatosin, Charles V. Pollack Jr.

Open Access Ulcerative Colitis Original Research

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Yohei Mikami, Takayuki Yamamoto, Satoshi Motoya, Shinichiro Shinzaki, Ryuichi Iwakiri, Kenkichi Sugiura, Kunihiko Nishimura, Mika Kajita, Jovelle L. Fernandez

Cystic Fibrosis Original Research

Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews

Christian Hoenig, Roald van der Laan, Andreas Reimann, Marina Hoffmann, Stephan Tyler, Claudia Wiesmann, Marko Obradovic

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.